030: Kyle Keeney | Part 2 A Bright Future for Your Community and for Your Family
Release Date: 04/11/2019
The Life Science Effect
Artificial intelligence is moving fast—but in regulated life science environments, speed without trust is a non‑starter. In this episode of The Life Science Effect, host Steven Vinson reacts to a recent EY article on AI validation in pharmaceutical and biotech settings and explores a fascinating question: Can AI actually be used to validate other AI systems? Steven walks through how regulators are beginning to rethink traditional validation models to accommodate AI’s non‑deterministic nature, where the same input can produce different, but still acceptable, outputs. Drawing parallels...
info_outlineThe Life Science Effect
In this episode, host Steve Vinson dives into one of the most futuristic — yet rapidly emerging — trends in life sciences: transportable and point‑of‑care pharmaceutical manufacturing. After discovering a compelling ISPE article, Steve explores how modular clean rooms, distributed manufacturing models, and space‑ready production units are reshaping the future of medicine. From personalized tablet production to on‑demand therapies in extreme environments, these technologies could redefine how and where healthcare happens. Drawing on his 30+ years in manufacturing, Steve connects...
info_outlineThe Life Science Effect
In this episode, Steve Vinson dives into a provocative article by US Senator Todd Young, exploring the shifting landscape of global biotech innovation. With China’s rapid advances—highlighted by a breakthrough lung cancer drug—Steve analyzes the factors behind America’s waning leadership, from fragmented policy and regulatory uncertainty to funding challenges and talent migration. Drawing on his own industry experience, Steve discusses the impact of immigration crackdowns, supply chain vulnerabilities, and the long-term effects of reshoring manufacturing. Listeners will gain insight...
info_outlineThe Life Science Effect
Step into the future of pharmaceutical and medical device innovation with Steve on The Life Science Effect. In this episode, Steve explores the transformative power of Pharma 4.0 and Validation 4.0, drawing insights from two thought-provoking blog posts by Robert Perks of Performance Validation. Discover how digital-first strategies, artificial intelligence, and continuous monitoring are reshaping compliance, quality assurance, and operational efficiency in life sciences. Steve breaks down the shift from paper-based systems to predictive analytics, highlighting the importance of aligning...
info_outlineThe Life Science Effect
In this thought-provoking Active Ingredient episode, host Steve Vinson tackles a leadership paradigm that's challenging everything he thought he knew about accountability. Inspired by on breaking people silos, Steve dives deep into the tension between traditional "one person accountable" thinking and the emerging concept of shared accountability across teams. Drawing from his real-world experience designing process lane diagrams that keep spanning across departments, Steve explores why Industry 4.0 might be demanding a complete rethink of how we structure organizations. He examines the...
info_outlineThe Life Science Effect
Meet Raul Zavaleta, the visionary engineer whose innovations fundamentally transformed how clinical trials collect and process data. In this captivating conversation, Raul shares the incredible journey from UCLA graduate to co-founder of what became Covance - one of the world's largest clinical research organizations. Discover how a simple frustration with keypunch cards led to revolutionary solutions that reduced clinical trial data error rates from 39% to under 2% and compressed data cleaning timelines from six months to 48 hours. Raul reveals the story behind the Zavacor system, the...
info_outlineThe Life Science Effect
In this episode, Steve reads and discusses an article by Jason Bork titled "Alzheimer's, a Disease to be Forgotten?," featured in the Indianapolis Business Journal's special supplement, Biofutures. Steve shares his off-the-cuff impressions and insights on Bork's article, which discusses the current state of Alzheimer's research, the challenges of clinical trials, and the progress made with recent FDA-approved drugs. He also reflects on the personal impact of Alzheimer's and the importance of ongoing research in Indiana. Tune in to hear Steve's thoughts and learn more about the advancements...
info_outlineThe Life Science Effect
This is the second installment of Active Ingredient. I read an article and answer a few questions about it. It's shorter than the regular episodes. I try to get to the key points of the article - the active ingredient. This episode is my off the cuff reaction to an article in the Indianapolis Business Journal by Daniel Lee, Animal-health startup BiomEdit advances poultry antibody, lands $20M in funding, grants. Here is a link to the article: Let me know what you think of the article and of my take in Active Ingredient. MUSIC: Acid Jazz-Kevin MacLeod used under the Creative Commons...
info_outlineThe Life Science Effect
Welcome to a new feature I am calling Active Ingredient. I read an article and answer a few questions about it. It's shorter than the regular episodes. I try to get to the key points of the article - the active ingredient. This episode is my off the cuff reaction to an article in Cure by Ryan Flinn called Europe Makes Bold Bid to Attract Biotech Amid FDA Uncertainty. Here is a link to the article: Let me know what you think of the article and of my take in Active Ingredient. MUSIC: Acid Jazz-Kevin MacLeod used under the Creative Commons Attribution 4.0 International License TRANSCRIPT:...
info_outlineThe Life Science Effect
In this mid-2025 update, The Life Science Effect explores the latest trends in pharma and medical devices—from regulatory upheaval under RFK Jr. and Dr. Makary to continued momentum in U.S. drug manufacturing. Learn how industry leaders are navigating clinical trial delays, FDA uncertainty, and global GLP-1 market expansion. Full transcript: Hey, everybody. Steve again, welcome back to the Life Science effect. If you're listening in the future, which most of you probably are, this may once again sound prophetic or maybe like a time capsule from a moment of flux. Today's updates a...
info_outlineThis is Part 2 of a two part conversation with Kyle Keeney, Entrepreneur-In-Residence, Elevate Ventures.
In Part 1, Kyle told the story of bringing his experience on the coasts, in Europe, and around the world back home to boost the economy in Southern Indiana/Northern Kentucky.
In part 2, Kyle describes how important it is for communities to take a long view when it comes to securing the future of innovation and sciences. Then, Kyle and Steve discuss some of their favorite books. Kyle tells Steve how he fosters a love of reading and learning in his children.
An experienced Chief Executive Officer with a demonstrated record of success in supporting innovation in life science and think tanks, Kyle offers the skills to build meaningful partnerships and relationships that cross boundaries to move science-based discoveries forward. With his business development skills and a focus on entrepreneurship, Kyle establishes novel collaborations, and fosters the commercialization of new technologies and ideas.
A proactive leader, Kyle encourages collaboration and communication, which serves as the foundation for bringing new ideas to fruition. He always seeks the opportunity to build new bridges as the means to fostering paths that lead to the emergence of capabilities in the sciences.
Resources mentioned in this episode:
https://www.ynharari.com/book/sapiens/
https://www.ynharari.com/book/21-lessons/
http://www.jareddiamond.org/Jared_Diamond/Guns,_Germs,_and_Steel.html
http://www.jareddiamond.org/Jared_Diamond/Collapse.html
https://www.goodreads.com/book/show/146153.What_Are_People_For_
https://www.simonandschuster.com/books/The-Tangled-Tree/David-Quammen/9781476776620
https://www.elevateventures.com/
http://communities.techstars.com/usa/indianapolis-in-usa/about